QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial

HLS Therapeutics (HLS) Earnings Date, Estimates & Call Transcripts

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free HLS Stock Alerts
C$4.95
+0.03 (+0.61%)
(As of 03:56 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider Trades

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Mar. 14)
-C$0.18 Missed By -C$0.05
Consensus EPS
(Mar. 14)
-C$0.13
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

HLS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HLS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

HLS Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241C($0.05)C($0.05)C($0.05)
Q2 20241C($0.01)C($0.01)C($0.01)
Q3 20241C$0.03C$0.03C$0.03
Q4 20241C$0.07C$0.07C$0.07
FY 20244C$0.04C$0.04C$0.04

HLS Earnings Date and Information

HLS Therapeutics last announced its quarterly earnings results on March 14th, 2024. The reported C($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.13) by C$0.05. The business had revenue of C$21.60 million for the quarter, compared to analyst estimates of C$21.83 million. HLS Therapeutics has generated C($1.16) earnings per share over the last year (C($1.16) diluted earnings per share). HLS Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

HLS Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)		------- 
3/14/2024Q4 2023C($0.13)C($0.18)C($0.05)C($0.13)C$21.83 millionC$21.60 million
11/9/2023Q3 2023C($0.16)C($0.28)C($0.12)C($0.28)C$21.97 millionC$21.52 million
8/10/2023Q2 2023C($0.17)C($0.39)C($0.22)C($0.39)C$21.17 millionC$22.05 million
5/11/2023Q1 2023C($0.16)C($0.24)C($0.08)C($0.24)C$21.26 millionC$19.96 million
3/16/2023Q4 2022C($0.09)C($0.27)C($0.18)C($0.27)C$22.56 millionC$21.28 million
11/10/2022Q3 2022C($0.11)C($0.18)C($0.07)C($0.18)C$21.50 millionC$20.49 million
8/11/2022Q2 2022C($0.08)C($0.36)C($0.28)C($0.36)C$21.40 millionC$19.82 million
5/5/2022Q1 2022C($0.10)C($0.14)C($0.04)C($0.14)C$19.39 millionC$18.44 million
3/17/2022Q4 2021C($0.12)C($0.16)C($0.04)C($0.16)C$20.47 millionC$19.78 million
11/4/2021Q3 2021C($0.15)C($0.08)+C$0.07C($0.08)C$19.56 millionC$18.96 million
8/5/2021Q2 2021C($0.21)C($0.08)+C$0.13C($0.08)C$18.33 millionC$18.36 million
5/6/2021Q1 2021C($0.25)C($0.19)+C$0.06C($0.19)C$18.41 millionC$18.13 million

HLS Therapeutics Earnings - Frequently Asked Questions

When is HLS Therapeutics's earnings date?

HLS Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on HLS's earnings history.

Did HLS Therapeutics beat their earnings estimates last quarter?

In the previous quarter, HLS Therapeutics (TSE:HLS) missed the analysts' consensus estimate of C($0.13) by C$0.05 with a reported earnings per share (EPS) of C($0.18). Learn more on analysts' earnings estimate vs. HLS's actual earnings.

How much revenue does HLS Therapeutics generate each year?

HLS Therapeutics (TSE:HLS) has a recorded annual revenue of C$63.07 million.

How much profit does HLS Therapeutics generate each year?

HLS Therapeutics (TSE:HLS) has a recorded net income of -C$27.53 million. HLS has generated -C$1.16 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (TSE:HLS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media